Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Operationalization and Use of Bispecific T-Cell–Engaging Antibodies in Community Practices: Multidisciplinary Perspectives on Developing Logistics and Workflow for Cytokine Release Syndrome Management

View through CrossRef
Objectives: Operationalizing workflows to manage cytokine release syndrome (CRS) in community practices presents challenges for multidisciplinary teams. Real-world experience was gathered from OneOncology community health-care professionals to establish best-practice workflows for CRS management. Methods: Qualitative data were gathered via focus groups from hematology-oncology MDs, PharmDs, and nurse providers (N = 13) with experience treating patients with bispecific T-cell–engaging antibodies (BsAbs). Theme matrix techniques facilitated analysis. Results: Three themes were identified: (1) creating a coordinated workflow plan, (2) building network partnerships, and (3) understanding patient support. Workflow decisions were driven by community practices managing patients treated with BsAbs or partnering with sites for initial dosing and maintenance. Catalysts for developing CRS workflows included: FDA approval of BsAbs; BsAbs clinical trial experience; BsAbs on formulary; having patients receiving BsAbs; and practice champion(s) for protocol development. Key steps included defining communication during and after practice hours, designating training leads, and creating practice-specific plans for interdisciplinary team coordination. Inpatient admission processes developed with hospital staff and hospital staff training were fundamental for successful patient management. Communication processes among practice, pharmacy, and hospital staff throughout BsAbs treatment were established, along with methods to ensure the availability of CRS treatment if needed. Continuous patient/caregiver education on BsAbs treatment, monitoring for adverse events (particularly CRS), and how/when to access care were described. Conclusions: BsAb use in community settings requires multidisciplinary coordination between practices and hospitals. Actions included identifying practice champions, establishing clear workflows for transitioning patients between inpatient and outpatient settings, and ensuring continuous training of staff, patients, and caregivers.
Title: Operationalization and Use of Bispecific T-Cell–Engaging Antibodies in Community Practices: Multidisciplinary Perspectives on Developing Logistics and Workflow for Cytokine Release Syndrome Management
Description:
Objectives: Operationalizing workflows to manage cytokine release syndrome (CRS) in community practices presents challenges for multidisciplinary teams.
Real-world experience was gathered from OneOncology community health-care professionals to establish best-practice workflows for CRS management.
Methods: Qualitative data were gathered via focus groups from hematology-oncology MDs, PharmDs, and nurse providers (N = 13) with experience treating patients with bispecific T-cell–engaging antibodies (BsAbs).
Theme matrix techniques facilitated analysis.
Results: Three themes were identified: (1) creating a coordinated workflow plan, (2) building network partnerships, and (3) understanding patient support.
Workflow decisions were driven by community practices managing patients treated with BsAbs or partnering with sites for initial dosing and maintenance.
Catalysts for developing CRS workflows included: FDA approval of BsAbs; BsAbs clinical trial experience; BsAbs on formulary; having patients receiving BsAbs; and practice champion(s) for protocol development.
Key steps included defining communication during and after practice hours, designating training leads, and creating practice-specific plans for interdisciplinary team coordination.
Inpatient admission processes developed with hospital staff and hospital staff training were fundamental for successful patient management.
Communication processes among practice, pharmacy, and hospital staff throughout BsAbs treatment were established, along with methods to ensure the availability of CRS treatment if needed.
Continuous patient/caregiver education on BsAbs treatment, monitoring for adverse events (particularly CRS), and how/when to access care were described.
Conclusions: BsAb use in community settings requires multidisciplinary coordination between practices and hospitals.
Actions included identifying practice champions, establishing clear workflows for transitioning patients between inpatient and outpatient settings, and ensuring continuous training of staff, patients, and caregivers.

Related Results

TABular Semantic Enhancement Blueprint (TAB-SEB) v1
TABular Semantic Enhancement Blueprint (TAB-SEB) v1
Project website link: https://ariannamorettj.github.io/tab_seb/ Overview Purpose. The workflow blueprint supports semantic enhancement of Cultural Heritage and GLAM metadata by c...
A review of mono- and bispecific genera of Amphibians worldwide
A review of mono- and bispecific genera of Amphibians worldwide
Monospecific and bispecific genera are of particular interest in studies of taxonomic diversity and speciation evolution. Here, the distribution patterns of mono- and bispecific am...
The influence of logistics management on food security in Ghana
The influence of logistics management on food security in Ghana
Research problem warehouse Food insecurity has been reported to be increasing in Ghana despite recent government logistics infrastructure (warehouses) efforts. It is important to u...
Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific
Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific
Introduction: T cell bispecific antibodies (TCBs), such as blinatumomab, mosunetuzumab or glofitamab, redirect T cells toward cancer cells and rely on endogenous T c...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Shared Use of Digital Logistics Services by Consumers and Manufacturers of Tourist Services
Shared Use of Digital Logistics Services by Consumers and Manufacturers of Tourist Services
The presented study examines the major directions for the application of digital technologies in tourism with an emphasis on the efficiency of digital technologies and digital logi...

Back to Top